Search Legislation

The Medicines (Products for Human Use) (Fees) Regulations 2016

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

  1. Introductory Text

  2. PART 1 General

    1. 1.Citation and commencement

    2. 2.Interpretation

  3. PART 2 Capital Fees for Pre-Application Meetings

    1. 3.Interpretation of Part 2

    2. 4.Fee for scientific advice: application for, or variation to, EU marketing authorisation

    3. 5.Fee for scientific advice: classification of a medicinal product

    4. 6.Fee for advertising advice

    5. 7.Fee for pharmacovigilance advice

    6. 8.Fee for advice on labelling or leaflets

    7. 9.Fee for regulatory advice

    8. 10.Fee for advice for other purposes

    9. 11.Time for payment of fees under regulations 4 to 10

  4. PART 3 Capital Fees for Applications for Authorisations, Registrations, Licences or Certificates and for Associated Inspections

    1. 12.Fees for applications for authorisations, registrations, licences or certificates etc.

    2. 13.Fee for application to be included on the list of online sellers of medicines

    3. 14.Fee for applications for additional copy certificates

    4. 15.Fees for applications for certificates and copy certificates by exporters of medicinal products

  5. PART 4 Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States

    1. 16.Meaning of “set of applications”

    2. 17.Fees for applications for regulatory assistance under the mutual recognition procedure

    3. 18.Time for payment of fees under regulation 17

  6. PART 5 Capital Fees for Applications for Variations of Authorisations, Registrations and Licences and for Associated Compliance Activities

    1. 19.Fees for variations of authorisations, registrations and licences

    2. 20.Fees for amendments to clinical trial authorisations

    3. 21.Fees for notification of changes and reports for broker’s registrations

    4. 22.Fees for notification of changes and compliance Reports for active substance registrations

    5. 23.Applications for multiple variations

  7. PART 6 Capital Fees for Assessment of Labels and Leaflets

    1. 24.Meaning of “set of proposed changes”

    2. 25.Fees for assessment of a set of proposed changes to labels and leaflets

    3. 26.Time for payment of fees under regulation 25

  8. PART 7 Capital Fees for Applications for Renewals of Certain Licences, Authorisations and Registrations and for Associated Inspections

    1. 27.Fees for renewals of certain manufacturer’s licences

    2. 28.Fees for renewals in terms which are not identical to the existing authorisation, licence or registration

  9. PART 8 Capital Fees for Regulatory Assistance Given by the United Kingdom Acting as Reference Member State Relating to the Assessment of Applications for the Renewal of Specified Marketing Authorisations

    1. 29.Fees for regulatory assistance for certain marketing authorisations

  10. PART 9 Capital Fees for Inspections

    1. 30.Fees for inspections

    2. 31.Fees for inspections of pharmacovigilance service providers

    3. 32.Payer of inspection fee (contract laboratories and API manufacturing sites)

    4. 33.Inspections in connection with multiple applications

    5. 34.Fees for inspections relating to good clinical practice in clinical trials

    6. 35.Amount, and time for payment, of inspection fees in respect of an application for a wholesale dealer’s licence

    7. 36.Adjustment and refund of inspection fees in respect of a wholesale dealer’s licence

    8. 37.Amount, and time for payment, of inspection fees in respect of an application for a broker’s registration or an active substance registration

  11. PART 10 Periodic Fees for Authorisations, Registrations and Licences

    1. 38.Periodic fees

    2. 39.Periodic fee for persons included on the list of online sellers of medicines

  12. PART 11 Capital Fees for Application for Membership of Good Clinical Practice Accreditation Scheme and for Certificate of Membership

    1. 40.Meaning of “good clinical practice accreditation scheme”

    2. 41.Fees for applications for membership and certificates

  13. PART 12 Capital Fee for a Review Upon Oral Representations or a Person Appointed Hearing

    1. 42.Fee for a review upon oral representations or a person appointed hearing

    2. 43.Time for payment under regulation 42

  14. PART 13 Fees in relation to the Part 6 of the Human Medicines Regulations (certification of homoeopathic medicinal products)

    1. 44.Interpretation

    2. 45.Fees for applications made at the invitation of the licensing authority

    3. 46.Fees for applications for certificates

    4. 47.Fees for variations of certificates

    5. 48.Time for payment of fees

  15. PART 14 Administration

    1. 49.Payment of fees to Ministers

    2. 50.Time for payment of capital fees in connection with applications or inspections

    3. 51.Time for payment of capital fees – applications made by small companies

    4. 52.Payment of fees in respect of a traditional herbal registration

    5. 53.Time for payment of periodic fees

    6. 54.Penalty fees for late payment of periodic fees

    7. 55.Daily penalty fees for late payment of periodic fees

    8. 56.Refund or waiver of fees under regulation 54 or 55

    9. 57.Adjustment, waiver, reduction or refund of fees

    10. 58.Suspension of licences and authorisations

    11. 59.Civil proceedings to recover unpaid fees

  16. PART 15 Amendments to Other Legislation

    1. 60.Amendment of the Medical Devices (Consultation Requirements) (Fees) Regulations 1995

    2. 61.Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004

    3. 62.Amendment of the Human Medicines Regulations 2012

  17. PART 16 Revocations and Savings

    1. 63.The Medicines (Products for Human Use) (Fees) Regulations 2013

  18. Signature

  19. SCHEDULES

    1. SCHEDULE 1

      General interpretation provisions

      1. 1.In these Regulations— “the 2001 Directive” means Directive 2001/83/EC of...

      2. 2.For the purposes of these Regulations, a clinical trial authorisation...

      3. 3.In these Regulations any reference to an application for the...

      4. 4.In these Regulations any reference to an application to be...

    2. SCHEDULE 2

      Capital fees for applications for, and variations to, marketing authorisations, licences, registrations and certificates

      1. PART 1 General: interpretation and categories of applications and variations

        1. 1.Interpretation

        2. 2.General: categories of Applications and Variations

        3. 3.Administrative variation application

        4. 4.Extension application

        5. 5.Complex application

        6. 6.Complex registration application

        7. 7.Complex variation application

        8. 8.Decentralised procedure application

        9. 9.Extended Type II Complex Variation Application

        10. 10.Major application

        11. 11.Mutual recognition procedure incoming application

        12. 12.New excipient variation application

        13. 13.New indication variation application

        14. 14.Parallel Import Licence application

        15. 15.Reclassification variation application

        16. 16.Reduced registration application

        17. 17.Simple application

        18. 18.Standard application

        19. 19.Standard registration application

        20. 20.Standard variation application

        21. 21.Standard variation application for a homoeopathic medicinal product

        22. 22.Type IB and Type II Applications

        23. 23.Type II Complex Variation Application

      2. PART 2 Capital Fees for Applications for Authorisations, Licences, Registrations and Certificates

        1. 24.Marketing authorisations

        2. 25.Fees where application includes reclassification

        3. 26.Fees where person holds clinical trial certificate

        4. 27.Joint development

        5. 28.Application for multiple authorisations

        6. 29.Authorisation for a national homoeopathic product

        7. 30.Manufacturer’s licences and authorisations

        8. 31.Wholesale dealer’s licences

        9. 32.Broker’s registrations

        10. 33.Active substance registrations

        11. 34.Clinical trial authorisations

        12. 35.Traditional herbal registrations

        13. 36.Online sellers of medicines

      3. PART 3 Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States

        1. 37.Outgoing mutual recognition applications

      4. PART 4 Capital Fees for Applications for Variations of Authorisations, Licences and Registrations

        1. 38.Marketing authorisations

        2. 39.Variation of marketing authorisations

        3. 40.Reclassification of marketing authorisations

        4. 41.Variation of marketing authorisation: national homoeopathic products

        5. 42.Variation of parallel import licence

        6. 43.Manufacturer’s authorisations and licences

        7. 44.Variation of manufacturer’s authorisations and licences

        8. 45.Wholesale dealer’s licences

        9. 46.Variation of wholesale dealer’s licence

        10. 47.Variation of a broker’s registration

        11. 48.Variation of an active substance registration

        12. 49.Clinical trial authorisations

        13. 50.Traditional herbal registrations

        14. 51.Identical variations

        15. 52.Complex Variation Applications

        16. 53.Multiple reclassification variation applications

      5. PART 5 Capital Fees for Assessment of Labels and Leaflets

        1. 54.A set of changes

        2. 55.More than one set of changes proposed

      6. PART 6 Capital Fees for Regulatory Assistance Given by the United Kingdom Acting as Reference Member State Relating to the Assessment of Applications for the Renewal of Specified Marketing Authorisations

        1. 56.Regulatory assistance

        2. 57.Regulatory assistance – same manufacturer

      7. PART 7 Relevant Substances

        1. 58.Substances listed for the purposes of paragraph 24(2)(b) and (4)(b) and 38(2)(b)

    3. SCHEDULE 3

      Fees for inspections

      1. 1.General provisions relating to fees for inspections

      2. 2.Fees: general

      3. 3.Traditional herbal medicinal products

      4. 4.Sites concerned with starting materials for traditional herbal medicinal products

      5. 5.Wholesale dealer’s licence: general

      6. 6.Wholesale dealer’s licence: traditional herbal medicinal products

      7. 7.Wholesale dealer’s licences: inspection of short duration

      8. 8.Broker’s registrations

      9. 9.Active substance registrations

      10. 10.Office-based inspections

    4. SCHEDULE 4

      Periodic fees for licences

      1. PART 1 Interpretation

        1. 1.In this Schedule— “anthroposophic product” means a medicinal product prepared...

      2. PART 2 Value of the Product Sold or Supplied

        1. 2.Determining the total value of the product

        2. 3.Manufacturer’s prices

        3. 4.Information requirements

      3. PART 3 Periodic Fees for Marketing Authorisations and Licences

        1. 5.Marketing authorisations

        2. 6.Marketing authorisation: where Part 2 of the Act applies

        3. 7.Marketing authorisation: derivatives

        4. 8.Number of fee periods

        5. 9.Authorisation for two or more kinds of medicinal product

        6. 10.Reduced fees

        7. 11.Manufacturer’s licences or manufacturing authorisations

        8. 12.Wholesale dealer’s licences

        9. 13.Wholesale dealer’s licences: evidence

        10. 14.Wholesale dealer’s licences: special medicinal products

        11. 15.Additional amount for manufacturer’s licences and wholesale dealer’s licences which relate to special medicinal products

        12. 16.Traditional herbal registrations

        13. 17.Online sellers of medicines

      4. PART 4 Types of Marketing Authorisation for which only One Periodic Fee is Payable

        1. 18.Parallel import licences

    5. SCHEDULE 5

      Fees for certificates of registration

    6. SCHEDULE 6

      Time for payment of capital fees: small companies

      1. 1.Interpretation

      2. 2.Major application

      3. 3.Complex application

      4. 4.Multiple application

      5. 5.Outgoing mutual recognition application

      6. 6.Application for traditional herbal registration

      7. 7.Traditional herbal registration: complex variation

      8. 8.Application for manufacturer’s licence, manufacturing authorisation or wholesale dealer’s licence

      9. 9.Inspection fees in connection with applications

    7. SCHEDULE 7

      Waiver, reduction or refund of capital fees

      1. 1.Interruptions of manufacture, assembly, sale or supply

      2. 2.Reclassification

      3. 3.Variation of a traditional herbal registration

      4. 4.Withdrawal of application in relation to marketing authorisation, traditional herbal registration or clinical trial authorisation

      5. 5.Withdrawal of application in relation to a certificate of registration

      6. 6.Withdrawal of application in relation to manufacturing authorisation, wholesale dealer’s licence, manufacturer’s licence, broker’s registration or active substance registration

      7. 7.Refusal of application for grant of marketing authorisation, traditional herbal registration or clinical trial authorisation

      8. 8.Parallel import licence

      9. 9.Surrender of marketing authorisation at same time as a variation application

      10. 10.Clinical trial authorisation

      11. 11.Scientific advice: paediatric indications

      12. 12.Refunds: treated as having been paid on account

    8. SCHEDULE 8

      Adjustment, reduction or refund of periodic fees

      1. 1.Refund on surrender or revocation of authorisation, registration or licence

      2. 2.Adjustment and refund: licences relating to imported special medicinal products

      3. 3.Refunds: treated as having been paid on account

  20. Explanatory Note

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources